scholarly journals Rapid Manufacture and Isolation of Highly Viable Interferon-γ Expressing Virus-Specific T Cells: Validation Results for the Virus-Specific Cytotoxic T-Lymphocyte Consortium for Refractory EBV, CMV, and Adenovirus Infections

2019 ◽  
Vol 25 (3) ◽  
pp. S363-S364
Author(s):  
Stephan Kadauke ◽  
Bryon D. Johnson ◽  
Lauren Harrison ◽  
Lynn C. O'Donnell ◽  
Youwei Wang ◽  
...  
2009 ◽  
Vol 200 (2) ◽  
pp. 236-243 ◽  
Author(s):  
Estibaliz Lazaro ◽  
Sasha Blue Godfrey ◽  
Pamela Stamegna ◽  
Tobi Ogbechie ◽  
Christopher Kerrigan ◽  
...  

1997 ◽  
Vol 13 (1) ◽  
pp. 33-39 ◽  
Author(s):  
MARC DUPUIS ◽  
MADHUSUDAN V. PESHWA ◽  
CLAUDIA BENIKE ◽  
SMRITI K. KUNDU ◽  
EDGAR G. ENGLEMAN ◽  
...  

2011 ◽  
Vol 129 (5) ◽  
pp. 1126-1136 ◽  
Author(s):  
Masaaki Toda ◽  
Linan Wang ◽  
Suguru Ogura ◽  
Mie Torii ◽  
Makoto Kurachi ◽  
...  

2000 ◽  
Vol 355 (1395) ◽  
pp. 361-362 ◽  
Author(s):  
Peter C. Doherty

The school of thought that owes allegiance to Ludwig Wittgenstein teaches that language conditions perceptions. When we use the term ‘cytotoxic T lymphocyte’ or ‘helper Tcell’ we tend to orientate our own thinking processes, and those of listeners or readers, down particular paths. Part of the problem is that we are often describing cell populations by functions that may either be a property of only a proportion of those that are being assayed, or are simply inferred from the expression of various cell–surface markers. The consequence can be a measure of confusion that might be avoided if we could communicate with greater clarity. Is it possible to achieve a better terminology that will be accepted generally? The following are some examples of why there may be some value in thinking about this.


2008 ◽  
Vol 31 (4) ◽  
pp. 385-393 ◽  
Author(s):  
Liane Daudt ◽  
Rita Maccario ◽  
Franco Locatelli ◽  
Ilaria Turin ◽  
Lucia Silla ◽  
...  

1982 ◽  
Vol 156 (3) ◽  
pp. 810-821 ◽  
Author(s):  
D H Schwartz ◽  
P C Doherty

Thymocytes and spleen cells from C57BL/6 mice (H-2b) neonatally tolerized to H-2k alloantigens do not generate an anti-vaccinia response restricted to H-2Kk when adoptively transferred to appropriate irradiated hosts. This is in sharp contrast to the case for negatively selected C57BL/6 spleen cells acutely depleted of alloreactivity. No evidence for suppression was found in cell mixture experiments. We have shown elsewhere that our neonatally tolerized animals have a centrally induced delection-type tolerance in the absence of obvious suppression.2 We now suggest that in the neonatally tolerized mouse, chronic, central delection of anti-H-2k clones during early T cell ontogeny eliminates the major source of cells able to give rise, via somatic mutation and expansion, to anti-H-2Kk + vaccinia specific cytotoxic T lymphocyte precursors (CTL-P) in the adult. A similar mechanism may operate in the (k + b) leads to b chimera; however, the presence of H-2kxb accessory and presenting cells may permit the eventual generation (via cross-stimulation) of an H-2k-restricted vaccinia-specific repertoire. This would account for our observation of such "aberrant recognition" CTL-P emerging in the spleens of older (k x b) leads to b chimeras.


Sign in / Sign up

Export Citation Format

Share Document